Document is current
Any future updates will be listed below
-
Authors
Hopkinson, Andrew https://orcid.org/0000-0002-8801-7485
Figueiredo, Francisco C.
- License Information
-
More Information
Article History
Received: 14 December 2024
Accepted: 4 April 2025
First Online: 14 May 2025
Declarations
:
: Andrew Hopkinson is the chief scientific officer and director of NuVision Biotherapies. Francisco Figueiredo reports no conflicts of interest in this work. The review was constructed independently entirely through academic channels, but NuVision kindly funded the publication fee.
: This narrative review is based entirely on previously published literature and does not contain any studies with human participants or animals performed by the authors. Ethics compliance is therefore not applicable.
